GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cryosite Ltd (ASX:CTE) » Definitions » Ending Cash Position

Cryosite (ASX:CTE) Ending Cash Position : A$5.93 Mil (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Cryosite Ending Cash Position?

Cryosite's Ending Cash Position for the quarter that ended in Dec. 2023 was A$5.93 Mil.

Cryosite's quarterly Ending Cash Position declined from Dec. 2022 (A$4.99 Mil) to Jun. 2023 (A$4.73 Mil) but then increased from Jun. 2023 (A$4.73 Mil) to Dec. 2023 (A$5.93 Mil).

Cryosite's annual Ending Cash Position increased from Jun. 2021 (A$3.88 Mil) to Jun. 2022 (A$5.34 Mil) but then declined from Jun. 2022 (A$5.34 Mil) to Jun. 2023 (A$4.73 Mil).


Cryosite Ending Cash Position Historical Data

The historical data trend for Cryosite's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryosite Ending Cash Position Chart

Cryosite Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.92 4.06 3.88 5.34 4.73

Cryosite Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.27 5.34 4.99 4.73 5.93

Cryosite Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Cryosite's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=5.341+-0.61
=4.73

Cryosite's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=4.731+1.196
=5.93


Cryosite Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Cryosite's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryosite (ASX:CTE) Business Description

Traded in Other Exchanges
N/A
Address
13a Ferndell Street, South Granville, Sydney, NSW, AUS, 2142
Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.

Cryosite (ASX:CTE) Headlines

No Headlines